Everolimus Versus Axitinib as Second-line Therapy in Metastatic Renal Cell Carcinoma: Experience From Institut Gustave Roussy

2017 ◽  
Vol 15 (6) ◽  
pp. e1081-e1088 ◽  
Author(s):  
Annalisa Guida ◽  
Laurence Albiges ◽  
Lisa Derosa ◽  
Yohann Loriot ◽  
Christophe Massard ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Metastatic Renal Cell Carcinoma ◽  
Renal Cell ◽  
Second Line ◽  
Second Line Therapy ◽  
Line Therapy

Clinical Benefit of Everolimus as Second-Line Therapy in Metastatic Renal Cell Carcinoma: The French Retrospective SECTOR Study

2016 ◽  
Vol 14 (6) ◽  
pp. e595-e607 ◽  
Author(s):  
Stéphane Oudard ◽  
Florence Joly ◽  
Lionnel Geoffrois ◽  
Brigitte Laguerre ◽  
Nadine Houede ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Metastatic Renal Cell Carcinoma ◽  
Clinical Benefit ◽  
Renal Cell ◽  
Second Line ◽  
Second Line Therapy ◽  
Line Therapy

Everolimus as second-line therapy for metastatic renal cell carcinoma: a ‘real-life’ study

2015 ◽  
Vol 11 (2) ◽  
pp. 219-224 ◽  
Author(s):  
Mimma Rizzo ◽  
Gaetano Facchini ◽  
Clementina Savastano ◽  
Giuseppe Di Lorenzo ◽  
Luigi De Lucia ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Metastatic Renal Cell Carcinoma ◽  
Renal Cell ◽  
Real Life ◽  
Second Line ◽  
Second Line Therapy ◽  
Life Study ◽  
Line Therapy ◽  
Real Life Study

Vinorelbine and interferon-α2c as second-line therapy in metastatic renal cell carcinoma

2000 ◽  
Vol 11 (3) ◽  
pp. 175-179 ◽  
Author(s):  
Manuela Schmidinger ◽  
Günther G Steger ◽  
Alexandra C Budinsky ◽  
Catharina Wenzel ◽  
Thomas Brodowicz ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Metastatic Renal Cell Carcinoma ◽  
Renal Cell ◽  
Second Line ◽  
Second Line Therapy ◽  
Line Therapy
Sign in / Sign up

Export Citation Format

Share Document